HEADER HYDROLASE 19-FEB-97 1ADZ TITLE THE SOLUTION STRUCTURE OF THE SECOND KUNITZ DOMAIN OF TISSUE FACTOR TITLE 2 PATHWAY INHIBITOR, NMR, 30 STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: TISSUE FACTOR PATHWAY INHIBITOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: FACTOR XA-BINDING DOMAIN (DOMAIN II); COMPND 5 SYNONYM: TFPI, EPI, LACI; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: BLOOD; SOURCE 6 TISSUE: BLOOD; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: JE5505; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFLAG KEYWDS HYDROLASE, INHIBITOR, COAGULATION EXPDTA SOLUTION NMR NUMMDL 30 AUTHOR M.J.M.BURGERING,L.P.M.ORBONS REVDAT 4 03-NOV-21 1ADZ 1 REMARK SEQADV REVDAT 3 24-FEB-09 1ADZ 1 VERSN REVDAT 2 01-APR-03 1ADZ 1 JRNL REVDAT 1 25-FEB-98 1ADZ 0 JRNL AUTH M.J.BURGERING,L.P.ORBONS,A.VAN DER DOELEN,J.MULDERS, JRNL AUTH 2 H.J.THEUNISSEN,P.D.GROOTENHUIS,W.BODE,R.HUBER,M.T.STUBBS JRNL TITL THE SECOND KUNITZ DOMAIN OF HUMAN TISSUE FACTOR PATHWAY JRNL TITL 2 INHIBITOR: CLONING, STRUCTURE DETERMINATION AND INTERACTION JRNL TITL 3 WITH FACTOR XA. JRNL REF J.MOL.BIOL. V. 269 395 1997 JRNL REFN ISSN 0022-2836 JRNL PMID 9199408 JRNL DOI 10.1006/JMBI.1997.1029 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.T.STUBBS II REMARK 1 TITL STRUCTURAL ASPECTS OF FACTOR XA INHIBITION REMARK 1 REF CURR.PHARM.DES. V. 2 543 1996 REMARK 1 REFN ISSN 1381-6128 REMARK 1 REFERENCE 2 REMARK 1 AUTH H.BRANDSTETTER,A.KUHNE,W.BODE,R.HUBER,W.VON DER SAAL, REMARK 1 AUTH 2 K.WIRTHENSOHN,R.A.ENGH REMARK 1 TITL X-RAY STRUCTURE OF ACTIVE SITE-INHIBITED CLOTTING FACTOR XA. REMARK 1 TITL 2 IMPLICATIONS FOR DRUG DESIGN AND SUBSTRATE RECOGNITION REMARK 1 REF J.BIOL.CHEM. V. 271 29988 1996 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 3 REMARK 1 AUTH A.VAN DE LOCHT,M.T.STUBBS,W.BODE,T.FRIEDRICH, REMARK 1 AUTH 2 C.BOLLSCHWEILER,W.HOFFKEN,R.HUBER REMARK 1 TITL THE ORNITHODORIN-THROMBIN CRYSTAL STRUCTURE, A KEY TO THE REMARK 1 TITL 2 TAP ENIGMA? REMARK 1 REF EMBO J. V. 15 6011 1996 REMARK 1 REFN ISSN 0261-4189 REMARK 1 REFERENCE 4 REMARK 1 AUTH M.T.STUBBS,R.HUBER,W.BODE REMARK 1 TITL CRYSTAL STRUCTURES OF FACTOR XA SPECIFIC INHIBITORS IN REMARK 1 TITL 2 COMPLEX WITH TRYPSIN: STRUCTURAL GROUNDS FOR INHIBITION OF REMARK 1 TITL 3 FACTOR XA AND SELECTIVITY AGAINST THROMBIN REMARK 1 REF FEBS LETT. V. 375 103 1995 REMARK 1 REFN ISSN 0014-5793 REMARK 1 REFERENCE 5 REMARK 1 AUTH K.PADMANABHAN,K.P.PADMANABHAN,A.TULINSKY,C.H.PARK,W.BODE, REMARK 1 AUTH 2 R.HUBER,D.T.BLANKENSHIP,A.D.CARDIN,W.KISIEL REMARK 1 TITL STRUCTURE OF HUMAN DES(1-45) FACTOR XA AT 2.2 A RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 232 947 1993 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 6 REMARK 1 AUTH K.D.BERNDT,P.GUNTERT,L.P.ORBONS,K.WUTHRICH REMARK 1 TITL DETERMINATION OF A HIGH-QUALITY NUCLEAR MAGNETIC RESONANCE REMARK 1 TITL 2 SOLUTION STRUCTURE OF THE BOVINE PANCREATIC TRYPSIN REMARK 1 TITL 3 INHIBITOR AND COMPARISON WITH THREE CRYSTAL STRUCTURES REMARK 1 REF J.MOL.BIOL. V. 227 757 1992 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DIANA REMARK 3 AUTHORS : GUNTERT,WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURES WERE CALCULATED USING REMARK 3 THE DIANA PROGRAM BUT WERE NOT FURTHER REFINED USING A FORCE REMARK 3 FIELD AND ENERGY MINIMIZATION AND/OR MOLECULAR DYNAMICS REMARK 3 CALCULATIONS REMARK 4 REMARK 4 1ADZ COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170700. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 310 REMARK 210 PH : 4.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : HOMONUCLEAR NOESY; COSY; TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : DRX600 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TRIAD NMR FROM TRIPOS TRIPOS REMARK 210 METHOD USED : DIANA REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 300 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 30 REMARK 210 CONFORMERS, SELECTION CRITERIA : LOWEST VALUE OF VARIABLE TARGET REMARK 210 FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 TYR A 2 -152.08 65.63 REMARK 500 1 ASP A 4 76.23 -69.61 REMARK 500 1 ASP A 6 -58.69 82.12 REMARK 500 1 LYS A 8 45.83 35.27 REMARK 500 1 LEU A 9 80.84 36.59 REMARK 500 1 GLU A 17 158.98 -46.93 REMARK 500 1 CYS A 23 108.29 -59.38 REMARK 500 1 TYR A 26 124.90 64.82 REMARK 500 1 ILE A 27 21.93 -146.41 REMARK 500 1 THR A 28 76.95 46.34 REMARK 500 1 LYS A 37 54.56 32.91 REMARK 500 1 CYS A 47 -97.17 -10.08 REMARK 500 1 LEU A 48 -132.53 -61.28 REMARK 500 1 ASN A 50 -155.07 -151.77 REMARK 500 1 ASN A 52 76.46 -60.13 REMARK 500 1 ASN A 53 66.40 -153.79 REMARK 500 1 CYS A 64 -82.40 -79.50 REMARK 500 1 GLU A 65 -29.99 -37.34 REMARK 500 1 ASP A 66 73.64 38.35 REMARK 500 1 ASN A 69 -88.35 42.84 REMARK 500 2 LYS A 3 -43.68 -177.79 REMARK 500 2 ASP A 5 -26.24 92.89 REMARK 500 2 ASP A 6 -72.28 -57.53 REMARK 500 2 LEU A 9 36.76 33.19 REMARK 500 2 GLU A 17 173.27 -52.30 REMARK 500 2 PRO A 20 -86.99 -73.45 REMARK 500 2 CYS A 23 -114.45 -75.81 REMARK 500 2 ARG A 24 -78.64 -167.54 REMARK 500 2 TYR A 26 112.93 82.80 REMARK 500 2 LYS A 43 -166.36 -62.27 REMARK 500 2 TYR A 44 -112.75 -158.70 REMARK 500 2 CYS A 47 -69.04 -9.70 REMARK 500 2 LEU A 48 -163.65 -121.06 REMARK 500 2 ASN A 50 -157.37 -145.87 REMARK 500 2 ASN A 52 64.75 -65.59 REMARK 500 2 CYS A 64 -82.25 -83.38 REMARK 500 2 GLU A 65 -32.89 -35.70 REMARK 500 2 ASP A 66 175.18 94.53 REMARK 500 3 TYR A 2 100.33 -59.56 REMARK 500 3 LEU A 9 -118.38 -141.32 REMARK 500 3 GLU A 17 135.81 -39.97 REMARK 500 3 ILE A 22 -78.68 -31.66 REMARK 500 3 CYS A 23 151.61 -33.93 REMARK 500 3 TYR A 26 153.71 -48.76 REMARK 500 3 ILE A 27 22.79 -153.24 REMARK 500 3 LYS A 37 52.41 32.73 REMARK 500 3 CYS A 47 -176.48 -51.73 REMARK 500 3 ASN A 50 -157.51 -172.09 REMARK 500 3 MET A 51 -84.79 -80.61 REMARK 500 3 ASN A 52 98.51 -30.56 REMARK 500 REMARK 500 THIS ENTRY HAS 562 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 1ADZ A 1 71 UNP P10646 TFPI1_HUMAN 107 182 SEQADV 1ADZ TYR A 2 UNP P10646 ASN 108 ENGINEERED MUTATION SEQADV 1ADZ LYS A 3 UNP P10646 ALA 109 CONFLICT SEQADV 1ADZ ASP A 4 UNP P10646 ASN 110 ENGINEERED MUTATION SEQADV 1ADZ ASP A 5 UNP P10646 ARG 111 ENGINEERED MUTATION SEQADV 1ADZ ASP A 6 UNP P10646 ILE 112 ENGINEERED MUTATION SEQADV 1ADZ ASP A 7 UNP P10646 ILE 113 ENGINEERED MUTATION SEQADV 1ADZ A UNP P10646 THR 115 DELETION SEQADV 1ADZ A UNP P10646 THR 116 DELETION SEQADV 1ADZ A UNP P10646 GLN 118 DELETION SEQADV 1ADZ A UNP P10646 GLN 119 DELETION SEQADV 1ADZ A UNP P10646 GLU 120 DELETION SEQRES 1 A 71 ASP TYR LYS ASP ASP ASP ASP LYS LEU LYS PRO ASP PHE SEQRES 2 A 71 CYS PHE LEU GLU GLU ASP PRO GLY ILE CYS ARG GLY TYR SEQRES 3 A 71 ILE THR ARG TYR PHE TYR ASN ASN GLN THR LYS GLN CYS SEQRES 4 A 71 GLU ARG PHE LYS TYR GLY GLY CYS LEU GLY ASN MET ASN SEQRES 5 A 71 ASN PHE GLU THR LEU GLU GLU CYS LYS ASN ILE CYS GLU SEQRES 6 A 71 ASP GLY PRO ASN GLY PHE HELIX 1 1 ASP A 12 PHE A 15 5 4 HELIX 2 2 ASN A 34 THR A 36 5 3 HELIX 3 3 LEU A 57 ILE A 63 1 7 SHEET 1 A 2 ARG A 29 ASN A 33 0 SHEET 2 A 2 GLN A 38 PHE A 42 -1 N PHE A 42 O ARG A 29 SSBOND 1 CYS A 14 CYS A 64 1555 1555 2.41 SSBOND 2 CYS A 23 CYS A 47 1555 1555 2.15 SSBOND 3 CYS A 39 CYS A 60 1555 1555 2.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1